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Background
Hepatitis C virus (HCV) is an important public health
problem worldwide. Immunological complications are
found in 40-74% of patients with HCV, as well as the
prevalence of HCV infection is higher among individuals
with these conditions, suggesting a pathogenetic virus
influence.
As a systemic pathology, autoimmunity may occur
even without hepatic manifestations. Studies indicate
that peripheral nervous system disorders have been
observed as complications of HCV infection. This case
report is about a 56 year old male patient with skin
scaly erythematous lesions and stellate hypo pigmented
spots, muscle atrophy of the extremities and peripheral
neuropathy march with diffuse muscle weakness asso-
ciated with a positive history of hepatitis.
Methods
Clinical, image and laboratoy records of Hospital das
Clínicas da FMUSP review. Skin biopsy, neurologyc
investigation and hepatits C treatment were performed.
Understanding the association between HCV and auto-
immune manifestations, may light to virus testing,
beyond to indicate antiviral e immunomodulatory
treatment.
Results
Biopsy of skin lesions showed inflammatory features, some
with fibrinoid necrosis. Electromyography demonstrated
myopathy and neuropathy pattern. Nerve biopsy revealed
vasculitic neuropathy. The patient was submitted to
hepatitis C treatment with purpose to control autoim-
mune manifestations, but had several collateral effects that
required avoidance of the drug. It was also tried several
immunosuppressive medications, but all tended to fail and
partially control was acquired with cyclosporine.
Conclusions
Imunossupressive treatment and hepatitis C treatment
should be used to control autoimmune manifestations
related to virus C infection.
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